Clinical Trial Update: Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of a recombinant anti-tumor and anti-virus protein for injection to treat advanced neuroendocrine tumors. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• Recombinant anti-tumor and anti-virus protein for injection

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Neuroendocrine Tumors | Phase 2 | Status: UNKNOWN